# Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients

> **NCT02042170** · PHASE2 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 46 (actual)

## Conditions studied

- Establishing Dose of Sr-hGH in ISS Patients

## Interventions

- **DRUG:** human growth hormone self-injection

## Key facts

- **NCT ID:** NCT02042170
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042170, "Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02042170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*